GSK co-leads investment in ‘disease rebalancing’ Adrestia Therapeutics
British pharma company also announces strategic collaboration agreement
Read More
Tag: Ahren
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
